Prognostic value of highly sensitive troponin T on cardiac events in patients with chronic kidney disease not on dialysis

Midori Hasegawa, Junichi Ishii, Fumihiko Kitagawa, Kyoko Kanayama, Hiroshi Takahashi, Yukio Ozaki, Yukio Yuzawa

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Serum troponin T levels using a highly sensitive assay (hsTnT) in patients with chronic kidney disease (CKD) not on dialysis have not been examined. The aim of this prospective cohort study was to investigate the association of hsTnT with cardiac events in ambulatory CKD patients not on dialysis. The serum hsTnT level was measured in 442 ambulatory CKD patients not on dialysis whose estimated glomerular filtration rate was <60 ml/min/1.73 m2. Patients were divided into quartiles according to hsTnT levels, and were followed up for 3 years. Cardiac events were defined as a cardiac death, acute myocardial infarction, unstable angina pectoris that required emergency coronary revascularization, or hospitalization for worsening heart failure. During the follow-up period (median 22 months), 63 cardiac events occurred. Kaplan-Meier incidence rates of cardiac events for 3 years were 0.88 %, 11.5 %, 19.0 %, and 41.4 % among quartiles of hsTnT levels (P < 0.0001). After adjusting for other confounders, elevated hsTnT level was an independent predictor for cardiac events (hazard ratio 6.18, 95 % confidence interval 1.38-27.7, P = 0.0080 for highest quartile vs lowest quartile). In addition, C-index for receiver-operating characteristic curves for cardiac events was greater in an established risks plus hsTnT model than in the established risk alone model (0.857 vs 0.844, P = 0.026). Using a highly sensitive assay, serum hsTnT level was shown to be an independent predictor of cardiac events and a promising risk stratification tool in patients with CKD not on dialysis.

Original languageEnglish
Pages (from-to)473-479
Number of pages7
JournalHeart and Vessels
Volume28
Issue number4
DOIs
Publication statusPublished - 01-07-2013

Fingerprint

Troponin T
Chronic Renal Insufficiency
Dialysis
Serum
Unstable Angina
Glomerular Filtration Rate
ROC Curve
Hospitalization
Emergencies
Cohort Studies
Heart Failure
Myocardial Infarction
Prospective Studies
Confidence Intervals
Incidence

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

@article{0c902be03e224f3192a0af17f400b9d1,
title = "Prognostic value of highly sensitive troponin T on cardiac events in patients with chronic kidney disease not on dialysis",
abstract = "Serum troponin T levels using a highly sensitive assay (hsTnT) in patients with chronic kidney disease (CKD) not on dialysis have not been examined. The aim of this prospective cohort study was to investigate the association of hsTnT with cardiac events in ambulatory CKD patients not on dialysis. The serum hsTnT level was measured in 442 ambulatory CKD patients not on dialysis whose estimated glomerular filtration rate was <60 ml/min/1.73 m2. Patients were divided into quartiles according to hsTnT levels, and were followed up for 3 years. Cardiac events were defined as a cardiac death, acute myocardial infarction, unstable angina pectoris that required emergency coronary revascularization, or hospitalization for worsening heart failure. During the follow-up period (median 22 months), 63 cardiac events occurred. Kaplan-Meier incidence rates of cardiac events for 3 years were 0.88 {\%}, 11.5 {\%}, 19.0 {\%}, and 41.4 {\%} among quartiles of hsTnT levels (P < 0.0001). After adjusting for other confounders, elevated hsTnT level was an independent predictor for cardiac events (hazard ratio 6.18, 95 {\%} confidence interval 1.38-27.7, P = 0.0080 for highest quartile vs lowest quartile). In addition, C-index for receiver-operating characteristic curves for cardiac events was greater in an established risks plus hsTnT model than in the established risk alone model (0.857 vs 0.844, P = 0.026). Using a highly sensitive assay, serum hsTnT level was shown to be an independent predictor of cardiac events and a promising risk stratification tool in patients with CKD not on dialysis.",
author = "Midori Hasegawa and Junichi Ishii and Fumihiko Kitagawa and Kyoko Kanayama and Hiroshi Takahashi and Yukio Ozaki and Yukio Yuzawa",
year = "2013",
month = "7",
day = "1",
doi = "10.1007/s00380-012-0273-2",
language = "English",
volume = "28",
pages = "473--479",
journal = "Heart and Vessels",
issn = "0910-8327",
publisher = "Springer Japan",
number = "4",

}

Prognostic value of highly sensitive troponin T on cardiac events in patients with chronic kidney disease not on dialysis. / Hasegawa, Midori; Ishii, Junichi; Kitagawa, Fumihiko; Kanayama, Kyoko; Takahashi, Hiroshi; Ozaki, Yukio; Yuzawa, Yukio.

In: Heart and Vessels, Vol. 28, No. 4, 01.07.2013, p. 473-479.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prognostic value of highly sensitive troponin T on cardiac events in patients with chronic kidney disease not on dialysis

AU - Hasegawa, Midori

AU - Ishii, Junichi

AU - Kitagawa, Fumihiko

AU - Kanayama, Kyoko

AU - Takahashi, Hiroshi

AU - Ozaki, Yukio

AU - Yuzawa, Yukio

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Serum troponin T levels using a highly sensitive assay (hsTnT) in patients with chronic kidney disease (CKD) not on dialysis have not been examined. The aim of this prospective cohort study was to investigate the association of hsTnT with cardiac events in ambulatory CKD patients not on dialysis. The serum hsTnT level was measured in 442 ambulatory CKD patients not on dialysis whose estimated glomerular filtration rate was <60 ml/min/1.73 m2. Patients were divided into quartiles according to hsTnT levels, and were followed up for 3 years. Cardiac events were defined as a cardiac death, acute myocardial infarction, unstable angina pectoris that required emergency coronary revascularization, or hospitalization for worsening heart failure. During the follow-up period (median 22 months), 63 cardiac events occurred. Kaplan-Meier incidence rates of cardiac events for 3 years were 0.88 %, 11.5 %, 19.0 %, and 41.4 % among quartiles of hsTnT levels (P < 0.0001). After adjusting for other confounders, elevated hsTnT level was an independent predictor for cardiac events (hazard ratio 6.18, 95 % confidence interval 1.38-27.7, P = 0.0080 for highest quartile vs lowest quartile). In addition, C-index for receiver-operating characteristic curves for cardiac events was greater in an established risks plus hsTnT model than in the established risk alone model (0.857 vs 0.844, P = 0.026). Using a highly sensitive assay, serum hsTnT level was shown to be an independent predictor of cardiac events and a promising risk stratification tool in patients with CKD not on dialysis.

AB - Serum troponin T levels using a highly sensitive assay (hsTnT) in patients with chronic kidney disease (CKD) not on dialysis have not been examined. The aim of this prospective cohort study was to investigate the association of hsTnT with cardiac events in ambulatory CKD patients not on dialysis. The serum hsTnT level was measured in 442 ambulatory CKD patients not on dialysis whose estimated glomerular filtration rate was <60 ml/min/1.73 m2. Patients were divided into quartiles according to hsTnT levels, and were followed up for 3 years. Cardiac events were defined as a cardiac death, acute myocardial infarction, unstable angina pectoris that required emergency coronary revascularization, or hospitalization for worsening heart failure. During the follow-up period (median 22 months), 63 cardiac events occurred. Kaplan-Meier incidence rates of cardiac events for 3 years were 0.88 %, 11.5 %, 19.0 %, and 41.4 % among quartiles of hsTnT levels (P < 0.0001). After adjusting for other confounders, elevated hsTnT level was an independent predictor for cardiac events (hazard ratio 6.18, 95 % confidence interval 1.38-27.7, P = 0.0080 for highest quartile vs lowest quartile). In addition, C-index for receiver-operating characteristic curves for cardiac events was greater in an established risks plus hsTnT model than in the established risk alone model (0.857 vs 0.844, P = 0.026). Using a highly sensitive assay, serum hsTnT level was shown to be an independent predictor of cardiac events and a promising risk stratification tool in patients with CKD not on dialysis.

UR - http://www.scopus.com/inward/record.url?scp=84880270253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880270253&partnerID=8YFLogxK

U2 - 10.1007/s00380-012-0273-2

DO - 10.1007/s00380-012-0273-2

M3 - Article

VL - 28

SP - 473

EP - 479

JO - Heart and Vessels

JF - Heart and Vessels

SN - 0910-8327

IS - 4

ER -